Karen M. Anderson is Chief People Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 71,525 shares of CNTA, which is worth approximately $1.22 Million. The most recent transaction as insider was on Mar 25, 2024, when has been sold 51,160 shares (Ordinary Shares) at a price of $11.94 per share, resulting in proceeds of $610,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.5K
0% 3M change
33.19% 12M change
Total Value Held $1.22 Million

Karen M. Anderson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 25 2024
SELL
Open market or private sale
$610,850 $11.94 p/Share
51,160 Reduced 41.7%
71,525 Ordinary Shares
Mar 25 2024
BUY
Exercise of conversion of derivative security
$176,850 $3.93 p/Share
45,000 Added 26.84%
122,685 Ordinary Shares
Feb 01 2024
SELL
Payment of exercise price or tax liability
$59,500 $8.19 p/Share
7,265 Reduced 8.55%
77,685 Ordinary Shares
Feb 01 2024
BUY
Grant, award, or other acquisition
-
31,250 Added 26.89%
84,950 Ordinary Shares
Feb 01 2023
BUY
Grant, award, or other acquisition
-
53,700 Added 50.0%
53,700 Ordinary Shares

Also insider at

MIME
Mimecast Ltd Technology
KMA

Karen M. Anderson

Chief People Officer
Lexington, MA

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA